
ARQT Technical Analysis Summary (NASDAQ)
Analyze ARQT on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerARQT Technical Analysis Summary (NASDAQ)
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Arcutis Biotherapeutics, Inc. on the NASDAQ is awaiting a decisive move. Technical conditions suggest Arcutis Biotherapeutics, Inc. is consolidating, awaiting a decisive move.
RSI (14): 46.56
Stochastic %K: 22.22
Williams %R: -75.34
Rate of Change (ROC): -13.70
Takeaway:Arcutis Biotherapeutics, Inc. shows weakening momentum, with sellers gaining the edge.
MACD: -0.32
ADX: 20.75
ATR (14): 1.58
CCI (14): -38.70
Takeaway:Arcutis Biotherapeutics, Inc. shows weakening trend signals, with bearish pressure building.
Takeaway:Arcutis Biotherapeutics, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:Arcutis Biotherapeutics, Inc. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:ARQT shows mixed signals in money flow analysis.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
Overall Recommendation:Arcutis Biotherapeutics, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.